ViaDerma, Inc. Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch VDRM and buy or sell other stocks, ETFs, and their options commission-free!

About VDRM

ViaDerma, Inc. manufactures and sells pharmaceutical related products. The company was founded on January 11, 2007 and is headquartered in Las Vegas, NV. 

CEO
Chris Ayo Otiko
CEOChris Ayo Otiko
Employees
—
Employees—
Headquarters
Las Vegas, Nevada
HeadquartersLas Vegas, Nevada
Founded
2007
Founded2007
Employees
—
Employees—

VDRM Key Statistics

Market cap
123.37K
Market cap123.37K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
252.68K
Average volume252.68K
High today
$0.0001
High today$0.0001
Low today
$0.0001
Low today$0.0001
Open price
$0.0001
Open price$0.0001
Volume
45.00K
Volume45.00K
52 Week high
$0.008
52 Week high$0.008
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

With a market cap of 123.37K, ViaDerma, Inc. Common Stock(VDRM) trades at $0.00.

During the trading session on 2026-10-10, ViaDerma, Inc. Common Stock(VDRM) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 45K, compared to an average daily volume of 252.68K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.01.

The stock's 52-week range extends from a low of $0.00 to a high of $0.01.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.